These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 16804505

  • 21. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ, Kang WH, Li Q, Tan QR.
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [Abstract] [Full Text] [Related]

  • 22. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA, Ketter TA, Kalali AH.
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [Abstract] [Full Text] [Related]

  • 23. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Muzina DJ, Elhaj O, Gajwani P, Gao K, Calabrese JR.
    Acta Psychiatr Scand Suppl; 2005 Oct; (426):21-8. PubMed ID: 15833097
    [Abstract] [Full Text] [Related]

  • 24. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM, Kasper S.
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [Abstract] [Full Text] [Related]

  • 25. Outcome in the pharmacologic treatment of bipolar disorder.
    Keck PE, McElroy SL.
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):15S-23S. PubMed ID: 8707996
    [Abstract] [Full Text] [Related]

  • 26. Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
    Ginsberg LD.
    Ann Clin Psychiatry; 2006 Apr; 18 Suppl 1():19-22. PubMed ID: 16754408
    [Abstract] [Full Text] [Related]

  • 27. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders.
    Emrich HM, Dose M, von Zerssen D.
    J Affect Disord; 1985 Apr; 8(3):243-50. PubMed ID: 3160736
    [Abstract] [Full Text] [Related]

  • 28. [Comparative efficacy and tolerability of carbamazepine and oxcarbazepine during long therapy of patients with bipolar and schizoaffective disorders].
    Mosolov SN, Kostiukova EG, Ladyzhenskiĭ MIa.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009 Apr; 109(10):36-41. PubMed ID: 20037568
    [Abstract] [Full Text] [Related]

  • 29. [Oxcarbazepine in the treatment of affective and schizoaffective disorders].
    Dietrich DE, Kropp S, Emrich HM.
    Fortschr Neurol Psychiatr; 2003 May; 71(5):255-64. PubMed ID: 12740757
    [Abstract] [Full Text] [Related]

  • 30. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
    Lin YH, Chien YL.
    J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
    [No Abstract] [Full Text] [Related]

  • 31. The use of three-dimensional similarity in assessing the risk of cross-reactivity between carbamazepine and psychotropic drugs.
    Le Louarn E, Barbaud A, Trechot P, Marcou G, Lepoittevin JP.
    Eur J Clin Pharmacol; 2014 Apr; 70(4):495-8. PubMed ID: 24408579
    [No Abstract] [Full Text] [Related]

  • 32. The broad spectrum of bipolar disorder: implications for research and practice -- a commentary.
    Young AH.
    J Psychopharmacol; 2008 Jun; 22(4):401; discussion 408. PubMed ID: 18635716
    [No Abstract] [Full Text] [Related]

  • 33. [Carbamazepine intolerance mimicking infectious mononucleosis: apropos of 3 cases].
    Merle De Boever C, Sotto A, Guillot B, Jourdan J.
    Therapie; 1999 Jun; 54(4):489-91. PubMed ID: 10667117
    [No Abstract] [Full Text] [Related]

  • 34. Mechanism of action of newer anticonvulsants.
    White HS.
    J Clin Psychiatry; 2003 Jun; 64 Suppl 8():5-8. PubMed ID: 12892535
    [Abstract] [Full Text] [Related]

  • 35. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842
    [Abstract] [Full Text] [Related]

  • 36. [Psychopharmacological combination therapy in bipolar disorder].
    Quante A, van Hall F, Anghelescu I.
    Fortschr Neurol Psychiatr; 2009 May 01; 77(5):252-62. PubMed ID: 19418383
    [Abstract] [Full Text] [Related]

  • 37. [Therapeutic evidence for manic episode].
    Terao T.
    Seishin Shinkeigaku Zasshi; 2011 May 01; 113(9):867-72. PubMed ID: 22117391
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
    Evins AE.
    J Clin Psychiatry; 2003 May 01; 64 Suppl 8():9-14. PubMed ID: 12892536
    [Abstract] [Full Text] [Related]

  • 39. The use of anticonvulsants in the aftermath of mania.
    Cookson J, Elliott B.
    J Psychopharmacol; 2006 Mar 01; 20(2 Suppl):23-30. PubMed ID: 16551669
    [Abstract] [Full Text] [Related]

  • 40. Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder.
    Malek-Ahmadi P, Hanretta AT.
    Ann Pharmacother; 2004 Nov 01; 38(11):1852-4. PubMed ID: 15479776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.